{"DataElement":{"publicId":"2685430","version":"1","preferredName":"AIDS Malignancy Consortium Patient Exclusion Clinical Trial Eligibility Criteria 052 Type","preferredDefinition":"the type of element of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by NCI.","longName":"AMC_PT_E_CTEC_052_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2518234","version":"1","preferredName":"AIDS Malignancy Consortium Patient Exclusion Clinical Trial Eligibility Criteria","preferredDefinition":"information relating to the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by the NCI.","longName":"AMC_PT_EXCLU_CTEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2518228","version":"1","preferredName":"AIDS Malignancy Consortium Patient","preferredDefinition":"Established in 1995 to carry out Phase I and II studies of innovative therapies for AIDS malignancies.:A person who requires medical care.","longName":"C19707:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS Malignancy Consortium","conceptCode":"C19707","definition":"Established in 1995 to carry out Phase I and II studies of innovative therapies for AIDS malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC96D39-08C6-6793-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2518232","version":"1","preferredName":"Exclusion Clinical Trial Eligibility Criteria","preferredDefinition":"Exclusion; the act of restricting entrance or barring from participation.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C25370:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exclusion Criteria","conceptCode":"C25370","definition":"Medical and/or social characteristics that prevent a subject from being allowed to participate in a clinical study, as outlined in the study protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC88111-1844-69E1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC88111-1855-69E1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2685432","version":"1","preferredName":"052 Exclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the type of clinical trial eligibility exclusion criteria for an AIDS Malignancy Consortium 052 protocol.","longName":"052_EXCL_CTEC_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"240","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Does the participant have an allergy to yeast or any other components of Gardasil","valueDescription":"Does the participant have an allergy to yeast or any other components of Gardasil","ValueMeaning":{"publicId":"2685437","version":"1","preferredName":"Does the participant have an allergy to yeast or any other components of Gardasil","longName":"2685437","preferredDefinition":"Does the participant have an allergy to yeast or any other components of Gardasil","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BAF7DC5-AA32-12EC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BAF7DC5-AA5B-12EC-E044-0003BA3F9857","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"ONEDATA","dateModified":"2007-10-04","deletedIndicator":"No"},{"value":"Does the participant have active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements","valueDescription":"Does the participant have active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements","ValueMeaning":{"publicId":"2685438","version":"1","preferredName":"Does the participant have active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements","longName":"2685438","preferredDefinition":"Does the participant have active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BAECA1C-EE8A-15D7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BAF7DC5-AA49-12EC-E044-0003BA3F9857","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"ONEDATA","dateModified":"2007-10-04","deletedIndicator":"No"},{"value":"Has the participant undergone a splenectomy","valueDescription":"Has the participant undergone a splenectomy","ValueMeaning":{"publicId":"2685436","version":"1","preferredName":"Has the participant undergone a splenectomy","longName":"2685436","preferredDefinition":"Has the participant undergone a splenectomy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BAEA811-AAAA-1071-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BAF7DC5-AA6D-12EC-E044-0003BA3F9857","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"ONEDATA","dateModified":"2007-10-04","deletedIndicator":"No"},{"value":"Does the participant have hemophilia","valueDescription":"Does the participant have hemophilia","ValueMeaning":{"publicId":"2685435","version":"1","preferredName":"Does the participant have hemophilia","longName":"2685435","preferredDefinition":"Does the participant have hemophilia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BAF7DC5-AA22-12EC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BAF7DC5-AA7F-12EC-E044-0003BA3F9857","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"ONEDATA","dateModified":"2007-10-04","deletedIndicator":"No"},{"value":"Has the participant ever received Gardasil or any other HPV vaccine","valueDescription":"Has the participant ever received Gardasil or any other HPV vaccine","ValueMeaning":{"publicId":"2685433","version":"1","preferredName":"Has the participant ever received Gardasil or any other HPV vaccine","longName":"2685433","preferredDefinition":"Has the participant ever received Gardasil or any other HPV vaccine","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BAE9CFC-F450-1079-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BAF7DC5-AA91-12EC-E044-0003BA3F9857","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"ONEDATA","dateModified":"2007-10-04","deletedIndicator":"No"},{"value":"Does the participant have a history of anal or perianal carcinoma","valueDescription":"Does the participant have a history of anal or perianal carcinoma","ValueMeaning":{"publicId":"2685443","version":"1","preferredName":"Does the participant have a history of anal or perianal carcinoma","longName":"2685443","preferredDefinition":"Does the participant have a history of anal or perianal carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BAE9CFC-F470-1079-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BAEA811-AAD1-1071-E044-0003BA3F9857","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"ONEDATA","dateModified":"2007-10-04","deletedIndicator":"No"},{"value":"Does the participant have a history of high grade AIN (i.e. AIN 2 or 3) or high grade perianal intraepithelial neoplasia","valueDescription":"Does the participant have a history of high grade AIN (i.e. AIN 2 or 3) or high grade perianal intraepithelial neoplasia","ValueMeaning":{"publicId":"2685442","version":"1","preferredName":"Does the participant have a history of high grade AIN (i.e. AIN 2 or 3) or high grade perianal intraepithelial neoplasia","longName":"2685442","preferredDefinition":"Does the participant have a history of high grade AIN (i.e. AIN 2 or 3) or high grade perianal intraepithelial neoplasia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BAEA66B-452B-1223-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BAEA811-AAE3-1071-E044-0003BA3F9857","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"ONEDATA","dateModified":"2007-10-04","deletedIndicator":"No"},{"value":"Does the participant have a history of anal cytological result with HSIL, atypical squamous cells suggestive of HSIL, or suggestive of carcinoma","valueDescription":"Does the participant have a history of anal cytological result with HSIL, atypical squamous cells suggestive of HSIL, or suggestive of carcinoma","ValueMeaning":{"publicId":"2685441","version":"1","preferredName":"Does the participant have a history of anal cytological result with HSIL, atypical squamous cells suggestive of HSIL, or suggestive of carcinoma","longName":"2685441","preferredDefinition":"Does the participant have a history of anal cytological result with HSIL, atypical squamous cells suggestive of HSIL, or suggestive of carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BAE9CFC-F460-1079-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BAEA811-AAF5-1071-E044-0003BA3F9857","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"ONEDATA","dateModified":"2007-10-04","deletedIndicator":"No"},{"value":"Has the participant received any systemic antineoplastic or immunomodulatory treatment, systemic corticosteroids, investigational vaccines, interleukins, interferons, growth factors, or IVIG, <=45 days prior to entry","valueDescription":"Has the participant received any systemic antineoplastic or immunomodulatory treatment, systemic corticosteroids, investigational vaccines, interleukins, interferons, growth factors, or IVIG, <=45 days prior to entry","ValueMeaning":{"publicId":"2685440","version":"1","preferredName":"Has the participant received any systemic antineoplastic or immunomodulatory treatment, systemic corticosteroids, investigational vaccines, interleukins, interferons, growth factors, or IVIG, <=45 days prior to entry","longName":"2685440","preferredDefinition":"Has the participant received any systemic antineoplastic or immunomodulatory treatment, systemic corticosteroids, investigational vaccines, interleukins, interferons, growth factors, or IVIG, <=45 days prior to entry","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BAE9183-1016-1075-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BAEA811-AB07-1071-E044-0003BA3F9857","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"ONEDATA","dateModified":"2007-10-04","deletedIndicator":"No"},{"value":"Did the participant have serious illness requiring systemic treatment and/or hospitalization within 45 days prior to entry","valueDescription":"Did the participant have serious illness requiring systemic treatment and/or hospitalization within 45 days prior to entry","ValueMeaning":{"publicId":"2685439","version":"1","preferredName":"Did the participant have serious illness requiring systemic treatment and/or hospitalization within 45 days prior to entry","longName":"2685439","preferredDefinition":"Did the participant have serious illness requiring systemic treatment and/or hospitalization within 45 days prior to entry","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BAEA811-AABA-1071-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BAEA811-AB19-1071-E044-0003BA3F9857","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"ONEDATA","dateModified":"2007-10-04","deletedIndicator":"No"},{"value":"Is the participant receiving anticoagulation therapy other than acetylsalicylic acid at the time of entry","valueDescription":"Is the participant receiving anticoagulation therapy other than acetylsalicylic acid at the time of entry","ValueMeaning":{"publicId":"2685444","version":"1","preferredName":"Is the participant receiving anticoagulation therapy other than acetylsalicylic acid at the time of entry","longName":"2685444","preferredDefinition":"Is the participant receiving anticoagulation therapy other than acetylsalicylic acid at the time of entry","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BAE9CFC-F480-1079-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3BAF7DC5-AAA3-12EC-E044-0003BA3F9857","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"ONEDATA","dateModified":"2007-10-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BAEA99A-2031-121F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"SHIDED","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Exclusion Criteria","type":"Preferred Question Text","description":"Exclusion Criteria","url":null,"context":"CTEP"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BAEA66B-450E-1223-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-04","modifiedBy":"CAMPBELB","dateModified":"2011-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}